TCL Archive Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now October 11, 1996
TCL Archive Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity October 28, 2011
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
